WOUND HEALING ACTIVITY OF STANDARDIZED BOVIN COLOSTRUM DERIVATIVES IN DIABETIC RATS

Rohit P. Mali; Dr Rakesh Kumar Jat; Vijay Wagh

doi:10.61280/tjpls.v10i4.139

Authors

Rohit P. Mali N.G.S.P.M.s College of Pharmacy, Brahma Valley Educational Campus, Anjaneri, Nashik-422 213, Maharashtra, India
Dr Rakesh Kumar Jat Institute of Pharmacy, Shri Jagdishprasad Jhabarmal Tibrewala University, Jhunjhunu , India
Vijay Wagh N.G.S.P.M.s College of Pharmacy, Brahma Valley Educational Campus, Anjaneri, Nashik-422 213, Maharashtra, India

DOI:

https://doi.org/10.61280/tjpls.v10i4.139

Keywords:

Diabetic wound healing, Standardized bovine colostrum, Standardized bovine colostrum derivatives, Wound size reduction, Histological analysis, Innovative treatments

Abstract

Diabetic wound healing remains a significant clinical challenge due to impaired cellular and molecular processes inherent in diabetes. This study investigates the potential therapeutic effect of Standardized Bovine Colostrum Derivatives (SBCD) on cutaneous wound healing in a diabetic rat model. The research aims to address the limited therapeutic options available for diabetic wound management and to explore the potential of SBCD as an innovative approach.

A comprehensive literature review establishes the context of the study, highlighting the complexities of diabetic wound healing and the need for novel interventions. The wound healing process involves intricate interactions between growth factors, cytokines, and cellular activities, which are disrupted in diabetic conditions. Existing treatments often fall short in achieving desired outcomes.

The methodology employed a well-designed experimental protocol involving diabetic rats divided into SBCD-treated and control groups. Wounds were created under controlled conditions, and SBCD was administered to the treatment group. The progression of wound healing was monitored through wound size measurements and histological analysis. Statistical techniques were employed to evaluate the significance of differences observed.

The results indicate that SBCD administration positively influences wound healing in diabetic rats. Comparative analysis of wound size reduction between the treatment and control groups demonstrates promising outcomes. Histological examination further elucidates the cellular changes associated with SBCD treatment, emphasizing its potential in addressing diabetic wound healing challenges.

The discussion interprets these findings within the context of existing literature, proposing potential mechanisms through which SBCD may accelerate wound healing. The implications of this research extend to clinical practice, where innovative treatments are urgently needed to mitigate the burden of diabetic wound complications. While the study presents valuable insights, it acknowledges limitations and suggests avenues for further investigation.

In conclusion, this research contributes to the understanding of diabetic wound healing and introduces Standardized Bovine Colostrum Derivatives as a potential therapeutic option. By bridging the gap between existing knowledge and innovative treatment strategies, this study lays the foundation for future research and clinical applications, ultimately offering renewed hope for effective diabetic wound management.

Downloads

Download data is not yet available.

References

Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. Journal of Clinical Investigation. 2007;117(5):1219-1222.

Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: Mechanisms, signaling, and translation. Science Translational Medicine. 2014;6(265):265sr6.

Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321.

Falanga V. Wound healing and its impairment in the diabetic foot. The Lancet. 2005;366(9498):1736-1743.

Singh N, Armstrong DG, Lipsky BA. Preventing Foot Ulcers in Patients With Diabetes. JAMA. 2005;293(2):217-228.

Playford RJ, Macdonald CE, Johnson WS. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. American Journal of Clinical Nutrition. 2000;72(1):5-14.

Rathore A, Verma M, Kumar P, Srivastava S, Verma M, Bhatia J. Bovine colostrum: An emerging nutraceutical. Journal of Complementary and Integrative Medicine. 2012;9(1):Article 21.

Isaksson G, Gustafsson L, Åkerström B, Sletten K. Studies on Bovine Colostral Proteins. I. Preliminary Characterization of a Protein from Bovine Colostrum, which Inhibits Lipid Peroxidation. BiochimicaetBiophysicaActa (BBA) - General Subjects. 1974;362(2):310-316.

Kelly GS. Bovine colostrums: A review of clinical uses. Alternative Medicine Review. 2003;8(4):378-394.

Nikolic I, Stojanovic I, Vujicic M, Fagone P, Mangano K, Stosic-Grujicic S, Nicoletti F, Saksida T. Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents. Immunobiology. 2017 Feb 1;222(2):272-9.

Fecteau G, Baillargeon P, Higgins R, Paré J, Fortin M. Bacterial contamination of colostrum fed to newborn calves in Québec dairy herds. The Canadian Veterinary Journal. 2002 Jul;43(7):523.

Deori K, Soren AD, Yadav AK. Toxicity assessment of Phlogacanthusthyrsiflorus, a traditionally used anthelmintic plant of India. Future Journal of Pharmaceutical Sciences. 2023 Dec;9(1):1-1.

Chen L, Mirza R, Kwon Y, DiPietro LA, Koh TJ. The murine excisional wound model: Contraction revisited. Wound Repair and Regeneration. 2015 Nov 12;23(6):874-7.

0020

Murad S, Anwar A, Piracha ZZ, Sultan A. LRIG1 expression during homeostasis and skin wound healing in mice. Journal of Biological Regulators and Homeostatic Agents. 2015 Oct 1;29(4):829-33.

Farahpour MR, Mirzakhani N, Doostmohammadi J, Ebrahimzadeh M. HydroethanolicPistaciaatlantica hulls extract improved wound healing process; evidence for mast cells infiltration, angiogenesis and RNA stability. International Journal of Surgery. 2015 May 1;17:88-98.